The expression of interleukin-17, interferon-gamma, and macrophage inflammatory protein-3 alpha mRNA in patients with psoriasis vulgaris

Li Jiawen , Li Dongsheng , Tan Zhijian

Current Medical Science ›› 2004, Vol. 24 ›› Issue (30) : 294 -296.

PDF
Current Medical Science ›› 2004, Vol. 24 ›› Issue (30) : 294 -296. DOI: 10.1007/BF02832018
Article

The expression of interleukin-17, interferon-gamma, and macrophage inflammatory protein-3 alpha mRNA in patients with psoriasis vulgaris

Author information +
History +
PDF

Abstract

To investigate the role of Interleukin-17 (IL-17), Interferon-gamma (IFN-γ), and macrophage inflammatory protein-3 alpha (MIP-3α) in the pathogenesis of psoriasis, reverse transcriptase-polymerase chain reaction (RT-PCR) was used to semi-quantitatively analyze the mRNA expression of IL-17, IFN-γ, and MIP-3α in 31 psoriatic lesions and 16 normal skin tissues. The results showed that the mRNA of the three cytokines was present in all specimens. And the expression level of IL-17 mRNA in skin lesions was 1.1416±0.0591, which was significantly higher than that in normal controls (0.8788±0.0344,P<0.001). The expression levels of IFN-γ mRNA were 1.1142±0.0561 and 0.9050±0.263, respectively, with significant difference (P<0.001). And the expression levels of MIP-3α mRNA in psoriatic lesions was 1.1397±0.0521, which was markedly higher than that in normal controls (0.8681±0.0308,P<0.001). These findings indicate that up-regulated expression of IL-17, IFN-γ, and MIP-3α might be involved in the pathogenesis of psoriasis.

Keywords

Psoriasis vulgaris / interleukin-17 / interferon-gamma / macrophage inflammatory protein-3 alpha

Cite this article

Download citation ▾
Li Jiawen, Li Dongsheng, Tan Zhijian. The expression of interleukin-17, interferon-gamma, and macrophage inflammatory protein-3 alpha mRNA in patients with psoriasis vulgaris. Current Medical Science, 2004, 24(30): 294-296 DOI:10.1007/BF02832018

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

FossiezF, DjossouO, ChomaratP, et al. . T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med, 1996, 183(6): 2593-2593

[2]

TeunissenM B, KoomenC W, WierengaE A, et al. . Interleukin-17 and interferon-gamma synergize in the enhancement of proinflammatory cytokine production by human keratinocytes. J Invest Dermatol, 1998, 111(4): 645-645

[3]

Dieu-NosjeanM C, MassacrierC, HomeyB, et al. . Macrophage inflammatory protein 3alpha is expressed at inflamed epithelial surfaces and is the most potent chemokine known in attracting Langerhans cell precursors. J Exp Med, 2000, 192(5): 705-705

[4]

HomeyB, Dieu-NosjeanM C, WiesenbornA, et al. . Upregulation of macrophage inflammatory protein-3 alpha/CCL20 and CC chemokine receptor 6 in psoriasis. J Immunol, 2000, 164(12): 6621-6621

[5]

ChabaudM, PageG, MiossecP, et al. . Enhancing effect of IL-1, IL-17, and TNF-alpha on macrophage inflammatory protein-3alpha production in rheumatoid arthritis: regulation by soluble receptors and Th2 cytokines. J Immunol, 2001, 167(10): 6015-6015

[6]

AustinLM, OzawaM, KikuchiT, et al. . The majority of epidermal T cells in psoriasis vulgaris lesions can produce type 1 cytokines, interferon-gamma, interleukin-2, and tumor necrosis factor-alpha, defining TCL (cytotoxic T lymphocyte) and TH1 effector populations: a type 1 differentiation bias is also measured in circulating blood T cells in psoriatic patients. J Invest Dermtol, 1999, 113(5): 752-752

[7]

NishibuA, HanGW, IwatsukiK, et al. . Overexpression of monocyte-derived cytokines in active psoriasis: a relation to coexistent arthropathy. J Dermatol Sci, 1999, 21(1): 63-63

[8]

AlbanesiC, ScarponiC, CavaniA, et al. . Interleukin-17 is produced by both Th1 and Th2 lymphocytes, and modulates interferon-gamma and interleukin-4-induced activation of human keratinocytes. J Invest Dermatol, 2000, 115(1): 81-81

AI Summary AI Mindmap
PDF

82

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/